Filing Details
- Accession Number:
- 0001144204-15-053636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-03 16:06:06
- Reporting Period:
- 2015-09-01
- Filing Date:
- 2015-09-03
- Accepted Time:
- 2015-09-03 16:06:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
352998 | Igi Laboratories Inc | IG | Biological Products, (No Disgnostic Substances) (2836) | 010355758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1555152 | Jason Grenfell-Gardner | C/O Igi Laboratories, Inc. 105 Lincoln Avenue Buena NJ 08310 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-01 | 84,048 | $7.94 | 187,624 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 28, 2015 and for the purpose of compliance by the Reporting Person with certain tax obligations.
- $7.9421 is the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.51 to $8.14. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.